Literature DB >> 5676003

The assay of anti-pyretic drugs in mice, using intracerebral injection of pyretogenins.

C H Cashin, C E Heading.   

Abstract

1. A simple, cheap, and reliable method is described for the screening of new compounds for anti-pyretic activity. It involves the intracerebral injection of a suitable pyretogenin in conscious mice.2. The pyretic response is related to the logarithm of the dose in a substantially linear manner when "E" Pyrogen is used.3. A selection of established anti-pyretic drugs were effective in oral doses approaching those used clinically, which shows that the method is unusually sensitive.4. The response to intracerebral pyretogenin is not unduly influenced by drugs known to cause hypothermia.5. It is suggested that "E" Pyrogen injected intracerebrally has a direct effect on the central nervous system, rather than an indirect action through release of endogenous pyrogen.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5676003      PMCID: PMC1703404     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  SOME BIOLOGICAL PROPERTIES OF 'IBUFENAC', A NEW ANTI-RHEUMATIC DRUG.

Authors:  S S ADAMS; E E CLIFFE; B LESSEL; J S NICHOLSON
Journal:  Nature       Date:  1963-10-19       Impact factor: 49.962

2.  ANTI-INFLAMMATORY AND ANTIPYRETIC PROPERTIES OF N-(2,6-DICHLORO-M-TOLYL)ANTHRANILIC ACID (CI-583).

Authors:  C V WINDER; J WAX; M WELFORD
Journal:  J Pharmacol Exp Ther       Date:  1965-06       Impact factor: 4.030

3.  Pyretogenic effects of bacterial lipopolysaccharide and the assay of antipyretic drugs in rats.

Authors:  C A WINTER; G W NUSS
Journal:  Toxicol Appl Pharmacol       Date:  1963-03       Impact factor: 4.219

4.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

Authors:  T J HALEY; W G MCCORMICK
Journal:  Br J Pharmacol Chemother       Date:  1957-03

5.  Comparative pharmacological and toxicological evaluation of N-acetyl-p-aminophenol, salicylamide, and acetylsalicylic acid.

Authors:  G C BOXILL; C B NASH; A G WHEELER
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1958-07

6.  The intracerebral effects of noradrenaline and its modification by drugs in the mouse.

Authors:  R T Brittain
Journal:  J Pharm Pharmacol       Date:  1966-09       Impact factor: 3.765

7.  Anti-inflammatory and antipyretic properties of N-(alpha,alpha,alpha-trifluoro-m-tolyl) anthranilic acid (CI-440; flufenamic acid).

Authors:  C V WINDER; J WAX; B SERRANO; E M JONES; M L McPHEE
Journal:  Arthritis Rheum       Date:  1963-02

8.  Anti-inflammatory, antipyretic and antinociceptive properties of N-(2,3-xylyl)anthranilic acid (mefenamic acid).

Authors:  C V WINDER; J WAX; L SCOTTI; R A SCHERRER; E M JONES; F W SHORT
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

9.  Observations on the site & mode of action of pyrogens in the rabbit brain.

Authors:  K E Cooper; W I Cranston; A J Honour
Journal:  J Physiol       Date:  1967-07       Impact factor: 5.182

10.  ANTI-INFLAMMATORY AND ANTIPYRETIC ACTIVITIES OF INDOMETHACIN, 1-(P-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID.

Authors:  C A WINTER; E A RISLEY; G W NUSS
Journal:  J Pharmacol Exp Ther       Date:  1963-09       Impact factor: 4.030

View more
  1 in total

1.  Fever produced by endotoxin injected into the hypothalamus of the monkey and its antagonism by salicylate.

Authors:  R D Myers; T A Rudy; T L Yaksh
Journal:  J Physiol       Date:  1974-11       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.